Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.18 -0.38 (-2.05%)
At close: Oct 22, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Amortization of Deferred Charges (2014)

Updated

Analysis

Sarepta Therapeutics (SRPT) Amortization of Deferred Charges (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,149.24 Bn 1,117.83 Bn 19.71 Bn
2 Johnson & Johnson 636.01 Bn 555.87 Bn 17.30 Bn
3 AbbVie 500.63 Bn 473.74 Bn 12.70 Bn
4 Merck 357.88 Bn 312.26 Bn 12.21 Bn
5 Novartis Ag 301.63 Bn 265.62 Bn 11.24 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn
7 Amgen 238.20 Bn 193.60 Bn 7.24 Bn
8 Gilead Sciences 194.85 Bn 169.05 Bn 6.22 Bn
9 Pfizer 171.94 Bn 118.58 Bn 10.94 Bn
10 Sarepta Therapeutics 1.85 Bn -1.38 Bn 251.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 615,000.00
Sep 30, 2014 690,000.00
Jun 30, 2014 608,000.00
Mar 31, 2014 519,000.00
API Access

Sarepta Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=SRPT&period=max&api_key=YOUR_API_KEY